Investigation of the Prevalence of High-Risk Human Papillomavirus, Human Herpesvirus-8, and Herpes Simplex Virus-2 in Cervical Biopsy Samples Using the Real-Time PCR Method
Open Access
- 17 July 2025
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (7) , 200
Abstract
Persistent high-risk human papillomavirus (HR-HPV) infection is closely associated with the development of cervical intraepithelial neoplasia (CIN) and cervical cancer. In recent years, the potential impact of viral co-infections on this process has also been investigated. This study investigated the presence of HR-HPV, HSV-1/2, and HHV-8 DNA in formalin-fixed paraffin-embedded (FFPE) cervical biopsy samples, as well as their association with lesion severity. A total of 276 FFPE cervical tissue samples were evaluated. Viral DNA was detected by real-time PCR. The samples were histopathologically classified as normal/non-dysplastic, low-grade (LSIL), and high-grade (HSIL) lesions. HR-HPV DNA was detected in 112 samples (40.6%), with the highest prevalence observed in the 30–39 age group (51.2%). Among the HPV-positive cases, 46.5% (52/112) had single-type infections, 32.1% (36/112) had multiple-type infections, and 21.4% (24/112) were untypable. Together, these categories accounted for all HPV-positive samples. The most common genotype was HPV-16 (16.7%). HHV-8 and HSV-2 DNA were not detected. HSV-1 DNA was detected in only three non-dysplastic, HPV-negative cervical samples. In conclusion, HR-HPV DNA was detected in 40.6% of cervical biopsy samples and showed a significant association with increasing histological severity, highlighting its critical role in the progression of cervical lesions. Although the absence of HHV-8 and HSV-2 suggests a limited contribution of these viruses to cervical disease, the use of a single real-time PCR assay limits the ability to draw generalized conclusions regarding their clinical relevance. Further large-scale, multicenter studies employing both tissue-based and serological approaches are needed to validate these findings and to better understand the dynamics of viral co-infections in cervical disease.Keywords
This publication has 51 references indexed in Scilit:
- Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening programCancer Medicine, 2023
- Knowledge, Attitudes and Behaviors of Women who have or have not had human papillomavirus vaccine in Turkey about the Virus and the vaccineJournal of Community Health, 2022
- Prevalence of active infection by herpes simplex virus type 2 in patients with high‐risk human papillomavirus infection: A cross‐sectional studyJournal of Medical Virology, 2020
- Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCRMethodsX, 2018
- Herpes simplex virus type 2 and the risk of cervical cancer: a meta-analysis of observational studiesArchives of Gynecology and Obstetrics, 2014
- Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2Journal of Medical Virology, 2012
- Efficient DNA Extraction for HPV Genotyping in Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics, 2011
- Prevalence of Kaposi's sarcoma‐associated herpesvirus infection in sex workers and women from the general population in SpainInternational Journal of Cancer, 2001
- Effect of herpes simplex virus on the DNA of human papillomavirus 18Journal of Medical Virology, 1997
- HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytesVirology, 1990